These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2100808)

  • 21. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
    Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B
    J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subacute sclerosing panencephalitis (SSPE); clinical and epidemiological observations of 56 cases studied from 1956 to 1978].
    Bergamini F; Breschi F; Ferrante P; D'Angelo A
    Minerva Med; 1981 Jan; 72(1):21-32. PubMed ID: 7465102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H; Andrews N; Brown KE; Miller E
    Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SSPE-epidemiology and measles vaccination: our cases.
    Vucenović V; Vranjesević D
    Neurologija; 1989; 38(1):23-31. PubMed ID: 2797378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of subacute sclerosing panencephalitis in Japan.
    Abe Y; Hashimoto K; Iinuma K; Ohtsuka Y; Ichiyama T; Kusuhara K; Nomura K; Mizuguchi M; Aiba H; Suzuki Y; Mizusawa H; Hosoya M
    J Child Neurol; 2012 Dec; 27(12):1529-33. PubMed ID: 22408143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subacute sclerosing panencephalitis: incidence among ethic groups in Israel.
    Soffer D; Rannon L; Alter M; Kahana E; Feldman S
    Isr J Med Sci; 1975 Jan; 11(1):1-4. PubMed ID: 1116935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing trend of SSPE over a period of ten years.
    Mishra B; Kakkar N; Ratho RK; Singhi P; Prabhakar S
    Indian J Public Health; 2005; 49(4):235-7. PubMed ID: 16479905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subacute sclerosing panencephalitis in children: prevalence in South China.
    Ip P; Chung BH; Wong VC; Chan KY
    Pediatr Neurol; 2004 Jul; 31(1):46-51. PubMed ID: 15246492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospects of measles and subacute sclerosing panencephalitis (SSPE) elimination in Poland].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska-Buksowicz B; Kulczycki J
    Neurol Neurochir Pol; 1999; 33(3):653-63. PubMed ID: 10540725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of patient age and year of developing the disease on immunologic response to measles virus in subacute sclerosing panencephalitis (SSPE)].
    Gut W; Kowalewska A
    Med Dosw Mikrobiol; 1993; 45(4):503-10. PubMed ID: 8189831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
    Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The continuous decrease in the number of SSPE annual cases ten years after compulsory anti-measles immunization.
    Cernescu C; Popescu-Tismana G; Alaicescu M; Popescu L; Cajal N
    Rev Roum Virol; 1990; 41(1):13-8. PubMed ID: 2223653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea.
    Takasu T; Mgone JM; Mgone CS; Miki K; Komase K; Namae H; Saito Y; Kokubun Y; Nishimura T; Kawanishi R; Mizutani T; Markus TJ; Kono J; Asuo PG; Alpers MP
    Epidemiol Infect; 2003 Oct; 131(2):887-98. PubMed ID: 14596530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan (1977-2005)].
    Hirayasu K; Oshiro S; Nakada Y
    No To Hattatsu; 2010 Nov; 42(6):427-31. PubMed ID: 21077352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Subacute sclerosing panencephalitis in Poland in the years 1971-1976. An epidemiological analysis].
    Naruszewicz-Lesiuk D; Kulczycki J; Iwińska B; Cendrowski W
    Przegl Epidemiol; 1979; 33(1):1-8. PubMed ID: 451230
    [No Abstract]   [Full Text] [Related]  

  • 37. [Subacute sclerosing panencephalitis: fulminant form].
    Grippo J; Cáceres L; Asís A; Grippo T; Ruprecht B; López M
    Rev Neurol; 2003 Mar 16-31; 36(6):536-9. PubMed ID: 12652417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Computerized analysis of the database of SSPE patients treated at the 1st Neurological Clinic of the Institute of Psychiatry and Neurology in Warsaw in 1978-1995].
    Milewska D; Kulczycki J; Sobczyk W
    Neurol Neurochir Pol; 1997; 31(3):475-91. PubMed ID: 9446041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subacute sclerosing panencephalitis in Italy. An epidemiological study.
    Cianchetti C; Ferrante P; Marrosu MG
    Acta Neurol Scand; 1986 Feb; 73(2):160-7. PubMed ID: 3705924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations of subacute sclerosing panencephalitis in South Africa.
    Schoub BD; Johnson S; McAnerney JM
    Trans R Soc Trop Med Hyg; 1992; 86(5):550-1. PubMed ID: 1475831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.